Veronica Conde - Publications

Real-world data of fulvestrant as first-line treatment of postmenopausal women with estrogen receptor-positive metastatic breast cancer.

Journal: Scientific reports

Published: September 23, 2020

Unusual long survival in a case of heterotaxy and polysplenia.

Journal: Surgical and radiologic anatomy : SRA

Published: April 11, 2020

Uncovering Tumour Heterogeneity through PKR and nc886 Analysis in Metastatic Colon Cancer Patients Treated with 5-FU-Based Chemotherapy.

Journal: Cancers

Published: January 15, 2020

A phase 2 study of panitumumab with irinotecan as salvage therapy in chemorefractory KRAS exon 2 wild-type metastatic colorectal cancer patients.

Journal: British journal of cancer

Published: December 07, 2018

Correction to: Efficacy of fulvestrant in the treatment of postmenopausal women with endocrine-resistant advanced breast cancer in routine clinical practice.

Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

Published: October 05, 2018

Genotype-based selection of treatment of patients with advanced colorectal cancer (SETICC): a pharmacogenetic-based randomized phase II trial.

Journal: Annals of oncology : official journal of the European Society for Medical Oncology

Published: November 18, 2017

Clinical and therapeutic potential of protein kinase PKR in cancer and metabolism.

Journal: Expert reviews in molecular medicine

Published: July 21, 2017

Efficacy of fulvestrant in the treatment of postmenopausal women with endocrine-resistant advanced breast cancer in routine clinical practice.

Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

Published: July 19, 2017